Conjugated Linoleic Acid [CLA] is actually a large group of isomers, but the c9,t11 & t10,c12 are the most studied, owing to greater presence.
By the time that I was using CLA over ten years ago, interest seemed already to be fading on the PCa sites I visited. Tonalin was the hyped product - from safflower oil. More promising supplements came along & I dropped CLA.
Only 13 PubMed hits for PCa-CLA in 15 years, and most are almost not worth mentioning, IMO. Very little U.S. research.
Most recent first:
[1] (2015 - Turkey)
"In vitro synergistic efficacy of conjugated linoleic acid, oleic acid, safflower oil and taxol cytotoxicity on PC3 cells."
"Cytotoxic synergy between Tax, OLA and CLA shows enhanced cytotoxicity on PC3 which might be used in the therapy of prostate cancer."
[2] (2013 - U.K.)
"Conjugated linoleic acid reduced cell proliferation and viability in all prostate cancer cell lines"
[3] (2011 - Argentina - Review)
[4] (2010 - Canada)
"Our results suggest that downregulation of FAS by 10,12 CLA, but not by the 9,11 isomer, as well as inhibition of FAS enzyme activity by both isomers, may contribute to growth inhibition of cancer cells but only at relatively high concentrations."
[5] (2008 - U.S. - Button Mushrooms contain CLA)
[6] (2007 - U.S. - Review)
[7] (2006 - Korea)
"trans-10,cis-12 conjugated linoleic acid inhibits the G1-S cell cycle progression in DU145 human prostate carcinoma cells."
[8] (2006 - U.K.)
"Induction of apoptosis and inhibition of NF-kappaB activation in human prostate cancer cells by the cis-9, trans-11 but not the trans-10, cis-12 isomer of conjugated linoleic acid."
[9] (2005 - France)
"Conjugated linoleic acid isomers and their conjugated derivatives inhibit growth of human cancer cell lines."
"Intensity of response of each tumor cell line to fatty acids. The intensities of response of the tumor cell lines to FA were different (Tables I to IV). Indeed, the lung (A-549), colon (DLD-1) and breast (T47D and MCF7) tumor cell lines were relatively sensitive, whereas the prostatic (PC3) and melanoma (M4Beu) tumor cell lines were more resistant to FA treatment."
[10] (2004 - U.K.)
"Conjugated linoleic acid inhibits proliferation and modulates protein kinase C isoforms in human prostate cancer cells."
[11] (2003 - Canada)
"Conjugated linoleic acid inhibits mutagenesis by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in the prostate of Big Blue rats."
[12] (2003 - U.S.)
"Effect of soy protein isolate and conjugated linoleic acid on the growth of Dunning R-3327-AT-1 rat prostate tumors."
"The results of this study indicate that neither an isoflavone-rich soy protein isolate (SPI), nor CLA inhibit the in vivo growth and development of prostate tumor cells when administered in the diet either singly or in combination. Moreover, at the highest concentrations SPI and CLA (i.e., 20% SPI, 1% CLA), there was a statistically significant increase in tumors volume over controls. Administration of SPI at 10% in the diet also enhanced tumor growth, whereas at 5%, SPI exerted no measurable effect. CLA administration alone had no observable effects on AT-1 tumor growth."
[13] (2002 - U.S.)
"The antiproliferative effects of biologically active isomers of conjugated linoleic acid on human colorectal and prostatic cancer cells."
"The t10,c12-CLA isomer exhibited the greatest potency against colorectal cancer proliferation, and the c9,t11 and t10,c12 isomers were moderately effective against prostate cancer."
-Patrick
[1] ncbi.nlm.nih.gov/pubmed/251...
[2] ncbi.nlm.nih.gov/pubmed/241...
[3] ncbi.nlm.nih.gov/pubmed/217...
[4] ncbi.nlm.nih.gov/pubmed/200...
[5] ncbi.nlm.nih.gov/pubmed/190...
[6] ncbi.nlm.nih.gov/pubmed/180...
[7] ncbi.nlm.nih.gov/pubmed/170...
[8] ncbi.nlm.nih.gov/pubmed/164...
[9] ncbi.nlm.nih.gov/pubmed/163...
[10] ncbi.nlm.nih.gov/pubmed/154...
[11] ncbi.nlm.nih.gov/pubmed/126...